Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nuvigil for Fatigue in Malignant Glioma Patients
NCT01400958Phase 2Terminated
- Sponsor
- Moffitt Cancer Center
- Start
- Dec 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of armodafinil in fatigue, sponsored by Moffitt Cancer Center. Started Dec 2010; status: terminated.
02
Drugs
armodafinil
03
Conditions
fatigue
Beyond the preview
Go deeper on NCT01400958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01400958.